Insiders · FDMT

FDMT insider transactions

4D Molecular Therapeutics Inc. (FDMT) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for FDMT

• 5d
  Officer Kirn David sold $19,258 worth of shares (1,922 units at $10.02) as part of a pre-agreed trading plan, decreasing direct ownership by 0.18% to 1,057,231 units (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 72d
  SEC Form 4 filed by Simms Christopher Paul

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 72d
  SEC Form 4 filed by Kirn David

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 72d
  SEC Form 4 filed by Bizily Scott

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 75d
  SEC Form 4 filed by Gupta Ashoo

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 151d
  SEC Form 4 filed by Director Sblendorio Glenn

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 151d
  SEC Form 3 filed by new insider Sblendorio Glenn

  3 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 166d
  VP, Finance and Controller Gupta Ashoo converted options into 1,086 shares and sold $3,377 worth of shares (389 units at $8.68), increasing direct ownership by 2% to 46,359 units (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 170d
  SEC Form 3 filed by new insider Simms Christopher Paul

  3 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 170d
  Chief Legal Officer Bizily Scott exercised 1,635 shares at a strike of $4.14 and sold $17,822 worth of shares (1,635 units at $10.90) (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 173d
  Director Theuer Charles exercised 9,333 shares at a strike of $1.14, increasing direct ownership by 29% to 41,684 units (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 178d
  SEC Form 4 filed by Chief Financial Officer Humer Kristian

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 178d
  SEC Form 3 filed by new insider Humer Kristian

  3 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 200d
  Chief Legal Officer Bizily Scott sold $17,315 worth of shares (1,635 units at $10.59) and exercised 1,635 shares at a strike of $4.14 (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 223d
  Chief Legal Officer Bizily Scott exercised 1,084 shares at a strike of $6.49 and sold $32,136 worth of shares (2,678 units at $12.00), decreasing direct ownership by 31% to 3,594 units (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 230d
  Chief Legal Officer Bizily Scott sold $16,628 worth of shares (1,635 units at $10.17) and exercised 1,635 shares at a strike of $4.14 (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 236d
  Chief Legal Officer Bizily Scott sold $24,080 worth of shares (2,408 units at $10.00), decreasing direct ownership by 32% to 5,188 units (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 240d
  New insider Gupta Ashoo claimed ownership of 45,662 shares (SEC Form 3)

  3 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 254d
  Chief Legal Officer Bizily Scott sold $19,256 worth of shares (2,407 units at $8.00), decreasing direct ownership by 24% to 7,596 units (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 352d
  SEC Form 4 filed by Director Chacko Jacob

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 352d
  SEC Form 4 filed by Director Gray Susannah

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 352d
  SEC Form 4 filed by Director Tomasello Shawn

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 352d
  SEC Form 4 filed by Director Theuer Charles

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 352d
  SEC Form 4 filed by Director Miller-Rich Nancy

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 352d
  SEC Form 4 filed by Director Milligan John F

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 454d
  SEC Form 4 filed by Chief Legal Officer Bizily Scott

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 454d
  SEC Form 4 filed by Chief Executive Officer Kirn David

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 454d
  SEC Form 4 filed by Chief Medical Officer Kim Robert Young

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 454d
  SEC Form 4 filed by Officer Mehra Uneek

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 454d
  SEC Form 4 filed by President & COO Kamal Fariborz

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 544d
  Large owner Ra Capital Management, L.P. disposed of 535,000 shares (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 559d
  New insider Ra Capital Management, L.P. claimed ownership of 5,098,211 shares (SEC Form 3)

  3 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 571d
  See Explanation of Responses Bvf Partners L P/Il disposed of 5,680,000 shares (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 627d
  Chief Legal Officer Bizily Scott exercised 500 shares at a strike of $6.49 and sold $8,165 worth of shares (500 units at $16.33) (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 655d
  Chief Legal Officer Bizily Scott exercised 500 shares at a strike of $6.49 and sold $7,500 worth of shares (500 units at $15.00) (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 675d
  New insider Bvf Partners L P/Il claimed ownership of 7,261,118 shares (SEC Form 3)

  3 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 689d
  Chief Legal Officer Bizily Scott exercised 1,750 shares at a strike of $7.60 and sold $47,442 worth of shares (1,750 units at $27.11) (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 692d
  Chief Legal Officer Bizily Scott exercised 1,996 shares at a strike of $15.78 and sold $49,900 worth of shares (1,996 units at $25.00) (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 695d
  Chief Executive Officer Kirn David exercised 12,923 shares at a strike of $14.55 and sold $290,598 worth of shares (12,923 units at $22.49) (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 704d
  Chief Legal Officer Bizily Scott exercised 4,248 shares at a strike of $7.55 and sold $90,758 worth of shares (4,248 units at $21.36) (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 711d
  Chief Executive Officer Kirn David exercised 12,930 shares at a strike of $14.42 and sold $298,711 worth of shares (12,930 units at $23.10) (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 717d
  Chief Legal Officer Bizily Scott sold $41,494 worth of shares (1,750 units at $23.71) and exercised 1,750 shares at a strike of $7.60 (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 745d
  SEC Form 4 filed by Tomasello Shawn

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 745d
  SEC Form 4 filed by Chacko Jacob

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 745d
  SEC Form 4 filed by Theuer Charles

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 745d
  SEC Form 4 filed by Miller-Rich Nancy

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 745d
  SEC Form 4 filed by Milligan John F

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 745d
  SEC Form 4 filed by Gray Susannah

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 748d
  Bizily Scott exercised 1,750 shares at a strike of $7.60 and sold $44,541 worth of shares (1,750 units at $25.45) (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 780d
  Bizily Scott exercised 1,750 shares at a strike of $7.60 and sold $45,045 worth of shares (1,750 units at $25.74) (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 795d
  Bizily Scott exercised 8,153 shares at a strike of $12.54 and sold $259,102 worth of shares (8,153 units at $31.78) (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 800d
  Bizily Scott exercised 5,833 shares at a strike of $25.98 and sold $204,410 worth of shares (5,833 units at $35.04) (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 809d
  Bizily Scott exercised 1,750 shares at a strike of $7.60 and sold $54,722 worth of shares (1,750 units at $31.27) (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 829d
  Bizily Scott exercised 1,909 shares at a strike of $20.24 and sold $57,270 worth of shares (1,909 units at $30.00) (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 837d
  Bizily Scott exercised 1,750 shares at a strike of $7.60 and sold $48,422 worth of shares (1,750 units at $27.67) (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 846d
  Bizily Scott exercised 6,244 shares at a strike of $10.18 and sold $171,710 worth of shares (6,244 units at $27.50) (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 846d
  Kirn David sold $2,495,822 worth of shares (92,001 units at $27.13), decreasing direct ownership by 8% to 1,059,153 units (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 851d
  Kim Robert Young exercised 24,000 shares at a strike of $15.29 and sold $737,788 worth of shares (24,552 units at $30.05), decreasing direct ownership by 35% to 1,043 units (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 851d
  New insider Kim Robert Young claimed ownership of 1,595 shares (SEC Form 3) (Amendment)

  3/A - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 864d
  Kirn David sold $104,851 worth of shares (5,696 units at $18.41), decreasing direct ownership by 0.49% to 1,151,154 units (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)